Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Knowing the average retirement savings for 30-year-olds helps gauge your financial health. Learn the benchmarks to aim for as you save.
23,529 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
AI market storms have created massive wealth for early believers. Explore a standout name that became this stock near...
Inflation data for May shows a 4.2% year-over-year rise, sparking notable moves in bitcoin (btc) price moves. Traders...
Moderna has surged in 2026, outpacing its vaccine peers as pipeline progress and a leadership refresh reshape the com...
New York City's Rent Guidelines Board approved a rent freeze for one-year renewals and, for the first time, two-year ...
Netflix posts solid Q1 growth driven by an ad-supported tier, while Comcast faces margin pressure from sports costs a...
This analysis breaks down what investors should watch in first horizon (fhn) 2026 earnings, with clear guidance on me...
Salesforce posted a solid Q4 with non-GAAP earnings beating estimates, but the stock sank as investors questioned gro...
As Guidewire charts its path through cloud adoption and insurer modernization, guidewire (gwre) 2026 earnings become ...
Cloudflare shares climbed about 8% on the day as investors bet NVIDIA’s AI acceleration will push more traffic throug...
Palantir surged into focus after blowout Q1 results and a fresh Buy rating from Argus with a $190 target, raising que...
Bitcoin faces a pivotal crossroad as the 4-year cycle motif intersects ETF-driven demand and the lingering effects of...